Cytomegalovirus retinitis associated with acquired immunodeficiency syndrome

Chinese Medical Journal

Volumn 124, Issue 8, 2011, Pages 1134-1138

  Geng, Shuang ^a   Ye, Jun Jie ^a   Zhao, Jia Liang ^a   Li, Tai Sheng ^a   Han, Yang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Acquired immunodeficiency syndrome; Cytomegalovirus retinitis; Ganciclovir

Indexed keywords

GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTERIOR EYE SEGMENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS RETINITIS; DISEASE ASSOCIATION; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTIC NERVE ATROPHY; OUTCOME ASSESSMENT; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA VASCULITIS; RETINOPATHY; RETROSPECTIVE STUDY; TREATMENT PLANNING; VISUAL ACUITY; VITREOUS OPACITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; FEMALE; FLUORESCEIN ANGIOGRAPHY; GANCICLOVIR; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79955503056     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.08.003     Document Type: Article

References (21)

1. Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol 2004; 49: 131-157.
2. Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology 2007; 114: 591-598.
3. Deayton JR, Wilson P, Sabin CA, Davey CC, Johnson MA, Emery VC, et al. Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy. AIDS 2000; 14: 1163-1170.
4. Davis JL. Differential diagnosis of CMV retinitis. Ocul Immunol Inflamm 1999; 7: 159-166.
5. Goldberg DE, Smithen LM, Angelilli A, Freeman WR. HIV-associated retinopathy in the HAART era. Retina 2005; 25: 633-649.
6. Dai Y, Qiu ZF, Li TS, Han Y, Zuo LY, Xie J, et al. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy. Chin Med J 2006; 119: 1677-1682.
7. Louwagie GM, Bachmann MO, Meyer K, Booysen FL, Fairall LR, Heunis C. Highly active antiretroviral treatment andhealth related quality of life in South African adults with human immunodeficiency virus infection: a cross-sectional analytical study. BMC Public Health 2007; 7: 244
8. Skiest DJ, Chiller T, Chiller K, Park A, Keiser P. Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis. Int J STD AIDS 2001; 12: 659-664.
9. Wong KH, Chan KC, Lee SS. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 39: 853-860.
10. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Studies of the Ocular Complications of AIDS Research Group. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 2007; 114: 787-793.
11. Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006; 113: 1441-1445.
12. Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis. Retina 2001; 21: 339-343.
13. Hoover DR, Peng Y, Saah A, Semba R, Detels RR, Rinaldo CR Jr, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996; 114: 821-827.
14. Zhao JL. Fundus features of acquired immunodeficiency syndrome. Zhang CF, Editor in chief. Retina. Beijing: People's Medical Publishing House. 1998: 662-673.
15. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis. Am J Ophthalmol 2005; 139: 1028-1034.
16. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, et al. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology 2004; 111: 2232-2239.
17. Sison RF, Holland GN, MacArthur LJ, Wheeler NC, Gottlieb MS. Cytomegalovirus retinopathy as the initial manifestation of the acquired immunodeficiency syndrome. Am J Ophthalmol 1991; 112: 243-249.
18. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Studies of the Ocular Complications of AIDS Research Group. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology 2007; 114: 780-786.
19. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis 1992; 166: 1223-1227.
20. Holland GN, Sison RF, Jatulis DE, Haslop MG, Sakamoto MJ, Wheeler NC. Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group. Ophthalmology 1990; 97: 204-211.
21. State Council AIDS Working Committee Office, UN Theme Group on AIDS in China. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2009). Beijing: Ministry of Health, China, 2009.